Diabetes Research
Sixty years ago, there weren’t any proven strategies to prevent diabetes complications like blindness, kidney disease, or heart disease. Today people with diabetes who control their blood glucose, blood pressure, and cholesterol can prevent or delay complications.
In the fifties, about one in five people with type 1 diabetes died within 20 years after diagnosis. Now, with proper care, these individuals can have a normal lifespan.
And recently, the FDA approved a medication to treat a diabetic eye disease that can cause people with both type 1 and type 2 diabetes to lose their eye sight.
Life has improved for people with diabetes, and research continues to offer hope.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is committed to sharing the latest in health information. Visit the websites below to learn more about current diabetes research or to participate in a clinical trial.
Clinical Trials
|
Learn about the importance of clinical trials, and browse the national database of publicly and privately supported clinical trials conducted around the world.
[Top]
|
Type 1 Diabetes Research
Type 2 Diabetes Research
NIDDK Research
|
Learn about NIDDK’s involvement in advancing diabetes research.
[Top]
|
Diabetes Research Resources
|
Read special reports about diabetes research, and learn more about practice guidelines, past clinical trials, and study results.
[Top]
|
Other Resources
|
Read, download, and order diabetes publications and resources.
- National Diabetes Information Clearinghouse
The National Diabetes Information Clearinghouse (NDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services. Established in 1978, the Clearinghouse provides information about diabetes to people with diabetes and to their families, health care professionals, and the public. The NDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about diabetes.
- National Diabetes Education Program
The National Diabetes Education Program is a federally funded program sponsored by the U.S. Department of Health and Human Services’ National Institutes of Health and the Centers for Disease Control and Prevention and includes over 200 partners at the federal, state, and local levels, working together to reduce the morbidity and mortality associated with diabetes.
[Top]
|
Clinical Trials
Learn about the importance of clinical trials, and browse the national database of publicly and privately supported clinical trials conducted around the world.
Browse clinical trials by topic and location, and learn more about relevant history, policies and laws.
[Top]
|
Type 1 Diabetes Research
Read about type 1 diabetes researche 1
[Top]
|
Type 2 Diabetes Research
| Read about recent type 2 diabetes research
[Top |
NIDDK Research
| Learn about NIDDK’s involvement in advancing diabetes research.
Browse NIDDK-funded diabetes research and resources.
Learn about research advances by NIDDK-funded scientists.
Learn about NIDDK’s accomplishments over the past 60 years in supporting and conducting research.
[Top]
|
Diabetes Research Resources
Read special reports about diabetes research, and learn more about practice guidelines, past clinical trials, and study results.
- AHRQ’s Clinical Practice Guidelines
Search for evidence-based clinical practice Guidelines provided by the Agency for Healthcare Research and Quality (AHRQ).
- Conquering Diabetes: Highlights of Program Efforts, Research Advances and Opportunities-A Scientific Progress Report on the Diabetes Research Working Group's Strategic Plan
Learn about the steps taken by the National Institutes of Health to implement the scientific recommendations made by the Diabetes Research Working Group, an independent, nongovernmental panel of experts.
- DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study
Learn about the results and implications of The Diabetes Control and Complications Trial and Follow-up Study, which was conducted by the NIDDK.
- Diabetes Prevention Program
Learn about the multicenter clinical research study aimed at discovering whether modest weight loss or treatment with an oral diabetes drug could prevent or delay the onset of type 2 diabetes.
- Diabetes, Type 1
Check out this NIH fact sheet to learn about type 1 Diabetes.
- Diabetes, Type 2
Check out this NIH fact sheet to learn about type 2 Diabetes.
- Special Statutory Funding Program for Type 1 Diabetes Research: Evaluation Report
Learn about the evaluation of the research programs supported by this special funding stream for research on type 1 diabetes and its complications.
- The Pima Indians: Pathfinders for Health
Learn how the Pima Indians helped researchers understand diabetes and ways in which NIDDK is working to improve clinical care and self-management practices among this group.
[Top]
|
Other Resources
Read, download, and order diabetes publications and resources.
- National Diabetes Information Clearinghouse
- The National Diabetes Information Clearinghouse (NDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK is part of the National Institutes of Health of the U.S. Department of Health and Human Services. Established in 1978, the Clearinghouse provides information about diabetes to people with diabetes and to their families, health care professionals, and the public. The NDIC answers inquiries, develops and distributes publications, and works closely with professional and patient organizations and Government agencies to coordinate resources about diabetes.
The National Kidney Education Program (NKDEP) is an initiative of the National Institute of Diabetes and Digestive and Kidney Diseases, Natioanl Institute of Health, U.S. Department of Health and Human Services. The NKDEP aims to raise awareness of the seriousness of kidney disease, the importance of testing those at high risk, and the availability of treatment to prevent or slow kidney disease.
[Top] |
Page last updated March 6, 2013